US Patent 7238341 Peptide-based multimeric targeted contrast agents
Patent 7238341 was granted and assigned to EPIX Pharmaceuticals, Inc. on July, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+146 characters)
Article
Patent abstract
Peptides and peptide-targeted multimeric contrast agents are described, as well as methods of making and using the contrast agents.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07238341 Peptide-based multimeric targeted contrast agents US Patent 7238341 Peptide-based multimeric targeted contrast agents
Infobox
Patent Number
0723834100
Patent Number
723834100
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072383410
Date of Patent
July 3, 2007
0Patent Application Number
107867910
Date Filed
February 25, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072383410
Date of Patent
July 3, 2007
0Patent Application Number
107867910
Date Filed
February 25, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07238341 Peptide-based multimeric targeted contrast agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07238341
Date of patent
July 3, 2007
Patent application number
10786791
Date Filed
February 25, 2004
Patent primary examiner
Find more entities like US Patent 7238341 Peptide-based multimeric targeted contrast agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
